Dieter David 4
4 · COLLEGIUM PHARMACEUTICAL, INC · Filed Mar 20, 2026
Research Summary
AI-generated summary of this filing
Collegium (COLL) EVP & GC Dieter David Sells 13,976 Shares
What Happened
Dieter David, EVP & General Counsel of Collegium Pharmaceutical, sold 13,976 shares on March 18, 2026. The weighted-average price was $34.92, with individual sale prices ranging from $34.74 to $35.39, producing total proceeds of approximately $488,099. The sales were reported as open-market/private sales (code S).
Key Details
- Transaction date: 2026-03-18 (reported on Form 4 filed 2026-03-20 — timely filing).
- Price: weighted average $34.92; individual prices ranged $34.74–$35.39 (footnote F2).
- Proceeds: ~$488,099 for 13,976 shares.
- Shares owned after transaction: Not disclosed in the provided filing.
- Footnotes: F1 — transaction effected under a Rule 10b5-1 trading plan adopted Dec 5, 2025; F2 — weighted-average price with range, and the filer will provide per-price breakdown on request.
- Transaction code: S (sale).
Context
Sales executed under a 10b5-1 plan are typically pre-arranged and can reflect scheduled, non-discretionary trading rather than a contemporaneous view of the company. For retail investors, purchases often carry clearer signals of insider conviction than routine sales; this filing is a recorded sale and should be interpreted as factual transaction activity without inferring motive.
Insider Transaction Report
- Sale
Common Stock
[F1][F2]2026-03-18$34.92/sh−13,976$488,099→ 77,071 total
Footnotes (2)
- [F1]The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025.
- [F2]The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.74 to $35.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.